Tao Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tao Xu has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Yangmei Chen
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
9 shared publications Chen Gong
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China
8 shared publicationsLiping Huang
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China
8 shared publicationsShuyu Jiang
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China
7 shared publicationsYou Wang
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China
7 shared publicationsJinxian Yuan
Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
6 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31 (1)
Targeting SLK protects against cerebral ischemia–reperfusion injury by regulating USP8-mediated HIF-1α stabilization and RhoA/ROCK activation
Introduction: Acute ischemic stroke (AIS) represents a major global contributor to mortality and chronic disability, with few effective therapeutic targets available. Identifying druggable genes associated with AIS is therefore critical for developing novel interventions. Methods: A comprehensive approach combining Mendelian randomization, multi-omics integration, and machine learning was employed to identify candidate druggable genes. Causal relationships were confirmed through genetic colocalization, and candidate genes were further validated in a retrospective clinical cohort comprising 60 patients who experienced AIS and 30 healthy controls. Functional and mechanistic investigations were performed using a male mouse middle cerebral artery occlusion/reperfusion (MCAO/R) model, oxygen–glucose deprivation/reperfusion (OGD/R) in HT22 cells, and 293 T cells. Results: SLK emerged as a genetically causal AIS gene and a central component of the optimal predictive model. Plasma SLK levels were elevated in patients who experienced AIS, demonstrating strong diagnostic and prognostic value and serving as an independent predictor of unfavorable 3-month outcomes after adjusting for age, sex, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Knockdown of SLK conferred neuroprotection both in vivo and in vitro. SLK interacted with and phosphorylated the deubiquitinase USP8, increasing its activity and suppressing K48-linked polyubiquitination and degradation of HIF-1α. HIF-1α was stabilized following activation of the RhoA/ROCK signaling pathway, aggravating ischemic injury, whereas USP8 overexpression mitigated the neuroprotective effects of SLK knockdown. Conclusions: These findings identify SLK as a neuron-specific proischemic factor and a potential therapeutic target, elucidate the SLK–USP8–HIF-1α–RhoA/ROCK pathway as a key mechanistic pathway, and highlight plasma SLK as a promising diagnostic and prognostic biomarker with translational relevance.
- 1 July 2026
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 31 (1)
Open AccessTargeting SLK protects against cerebral ischemia–reperfusion injury by regulating USP8-mediated HIF-1α stabilization and RhoA/ROCK activation
Introduction: Acute ischemic stroke (AIS) represents a major global contributor to mortality and chronic disability, with few effective therapeutic targets available. Identifying druggable genes associated with AIS is therefore critical for developing novel interventions. Methods: A comprehensive approach combining Mendelian randomization, multi-omics integration, and machine learning was employed to identify candidate druggable genes. Causal relationships were confirmed through genetic colocalization, and candidate genes were further validated in a retrospective clinical cohort comprising 60 patients who experienced AIS and 30 healthy controls. Functional and mechanistic investigations were performed using a male mouse middle cerebral artery occlusion/reperfusion (MCAO/R) model, oxygen–glucose deprivation/reperfusion (OGD/R) in HT22 cells, and 293 T cells. Results: SLK emerged as a genetically causal AIS gene and a central component of the optimal predictive model. Plasma SLK levels were elevated in patients who experienced AIS, demonstrating strong diagnostic and prognostic value and serving as an independent predictor of unfavorable 3-month outcomes after adjusting for age, sex, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Knockdown of SLK conferred neuroprotection both in vivo and in vitro. SLK interacted with and phosphorylated the deubiquitinase USP8, increasing its activity and suppressing K48-linked polyubiquitination and degradation of HIF-1α. HIF-1α was stabilized following activation of the RhoA/ROCK signaling pathway, aggravating ischemic injury, whereas USP8 overexpression mitigated the neuroprotective effects of SLK knockdown. Conclusions: These findings identify SLK as a neuron-specific proischemic factor and a potential therapeutic target, elucidate the SLK–USP8–HIF-1α–RhoA/ROCK pathway as a key mechanistic pathway, and highlight plasma SLK as a promising diagnostic and prognostic biomarker with translational relevance.
- 10 June 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- p. ajnr.A9462
Impact of DSA-based Cerebral Microcirculation Time on Neurological Improvement at Discharge in Stroke Patients after Successful Recanalization
Whether cerebral microcirculation influences the likelihood of early neurological improvement (ENI) is poorly understood in patients with acute ischemic stroke (AIS). We assessed the microcirculation time using digital subtraction angiography (DSA) and analyzed its impact on ENI at discharge and long-term outcomes in AIS treated by endovascular treatment. This was a retrospective cohort study of patients with AIS. All patients underwent standard cerebral DSA immediately after successful recanalization. We used the syngo iFlow software to assess the microvascular cerebral circulation time (mCCT) in the regions of interest on DSA. The primary outcome was ENI at discharge, defined as a decrease of ≥8 points or a National Institutes of Health Stroke Scale score of 0 or 1 when discharge. Logistic regression was conducted to analyze the impact of mCCT on prognosis. A total of 156 patients were included in the current study. The median age was 69 years, and 44.2% were male. Multivariate analysis showed that shorter mCCT was significantly associated with ENI at discharge (adjusted odds ratio[aOR] 4.79, 95% confidence interval [CI] 2.01-11.45, P<0.001) and functional independence at 90 days (aOR 3.64, 95% CI 1.53-8.67, P<0.001). The area under the receiver operating characteristic curve was significantly enhanced by including mCCT in the conventional model (0.830 vs 0.758, P=0.01, DeLong test). Finally, the mCCT model demonstrated good discrimination and calibration in this cohort, as well as the fivefold cross validation. DSA-based mCCT after successful recanalization is an independent predictor of ENI at discharge (aOR 4.79) and long-term functional outcomes (aOR 3.64).
- 10 June 2026
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- p. ajnr.A9462
Impact of DSA-based Cerebral Microcirculation Time on Neurological Improvement at Discharge in Stroke Patients after Successful Recanalization
Whether cerebral microcirculation influences the likelihood of early neurological improvement (ENI) is poorly understood in patients with acute ischemic stroke (AIS). We assessed the microcirculation time using digital subtraction angiography (DSA) and analyzed its impact on ENI at discharge and long-term outcomes in AIS treated by endovascular treatment. This was a retrospective cohort study of patients with AIS. All patients underwent standard cerebral DSA immediately after successful recanalization. We used the syngo iFlow software to assess the microvascular cerebral circulation time (mCCT) in the regions of interest on DSA. The primary outcome was ENI at discharge, defined as a decrease of ≥8 points or a National Institutes of Health Stroke Scale score of 0 or 1 when discharge. Logistic regression was conducted to analyze the impact of mCCT on prognosis. A total of 156 patients were included in the current study. The median age was 69 years, and 44.2% were male. Multivariate analysis showed that shorter mCCT was significantly associated with ENI at discharge (adjusted odds ratio[aOR] 4.79, 95% confidence interval [CI] 2.01-11.45, P<0.001) and functional independence at 90 days (aOR 3.64, 95% CI 1.53-8.67, P<0.001). The area under the receiver operating characteristic curve was significantly enhanced by including mCCT in the conventional model (0.830 vs 0.758, P=0.01, DeLong test). Finally, the mCCT model demonstrated good discrimination and calibration in this cohort, as well as the fivefold cross validation. DSA-based mCCT after successful recanalization is an independent predictor of ENI at discharge (aOR 4.79) and long-term functional outcomes (aOR 3.64).
- Open Access
- 12 December 2025
- Published by Springer Nature in Neurology and Therapy
- Vol. 15 (1) , 367-381
Association of Post-procedural Glucose with Clinical Outcomes After Endovascular Therapy for Large Vessel Occlusion
Introduction Glucose at admission predicted poor outcome for patients with acute large vessel occlusion (LVO) undergoing endovascular therapy (EVT). Prior studies ignored continuous glucose monitoring after EVT. Therefore, we aim to evaluate the association between post-procedural glucose levels and outcomes in real-world settings. Methods This study was based on a multicenter cohort. Patients with LVO who underwent EVT within 24 h of symptom onset were enrolled. We analyzed post-procedural blood glucose based on preprandial blood glucose levels within 48 h after EVT recognizing disrupted normal dietary patterns and circadian rhythms due to severe symptoms of LVO. Primary clinical outcome was functional independence (90-day modified Rankin scale score 0–2). We evaluated the association between post-procedural glucose and functional independence using logistic regression and assessed whether stroke severity modified this association. Results A total of 693 patients were included. Multivariate logistic regression analysis showed that decreased average post-procedural glucose per unit was significantly related to functional independence (adjusted odds ratio [aOR]: 0.75, 95% confidence interval [CI] 0.68–0.83, P < 0.001). Hyperglycemia was defined as any preprandial blood glucose within 48 h after EVT ≥ 7.6 mmol/L based on the restricted cubic spline regression model. The hyperglycemia group was also significantly associated with functional independence (aOR: 0.54, 95% CI 0.36–0.82, P = 0.003), symptomatic intracranial hemorrhage (aOR: 2.16, 95% CI 1.08–4.34, P < 0.001), and 90-day mortality (aOR: 1.71, 95% CI 1.04–2.79, P = 0.033). Subgroup analysis specifically in individuals with severe stroke (defined as National Institutes of Health Stroke Scale [NIHSS] ≥ 15) showed that hyperglycemia was a risk factor for low functional independence. Conclusion Increased post-procedural glucose is associated with poor functional outcome after endovascular treatment and an increased risk of symptomatic intracranial hemorrhage after endovascular treatment, especially for those with more severe strokes.
- 12 December 2025
- Published by Springer Nature in Neurology and Therapy
- Vol. 15 (1) , 367-381
Open AccessAssociation of Post-procedural Glucose with Clinical Outcomes After Endovascular Therapy for Large Vessel Occlusion
Introduction Glucose at admission predicted poor outcome for patients with acute large vessel occlusion (LVO) undergoing endovascular therapy (EVT). Prior studies ignored continuous glucose monitoring after EVT. Therefore, we aim to evaluate the association between post-procedural glucose levels and outcomes in real-world settings. Methods This study was based on a multicenter cohort. Patients with LVO who underwent EVT within 24 h of symptom onset were enrolled. We analyzed post-procedural blood glucose based on preprandial blood glucose levels within 48 h after EVT recognizing disrupted normal dietary patterns and circadian rhythms due to severe symptoms of LVO. Primary clinical outcome was functional independence (90-day modified Rankin scale score 0–2). We evaluated the association between post-procedural glucose and functional independence using logistic regression and assessed whether stroke severity modified this association. Results A total of 693 patients were included. Multivariate logistic regression analysis showed that decreased average post-procedural glucose per unit was significantly related to functional independence (adjusted odds ratio [aOR]: 0.75, 95% confidence interval [CI] 0.68–0.83, P < 0.001). Hyperglycemia was defined as any preprandial blood glucose within 48 h after EVT ≥ 7.6 mmol/L based on the restricted cubic spline regression model. The hyperglycemia group was also significantly associated with functional independence (aOR: 0.54, 95% CI 0.36–0.82, P = 0.003), symptomatic intracranial hemorrhage (aOR: 2.16, 95% CI 1.08–4.34, P < 0.001), and 90-day mortality (aOR: 1.71, 95% CI 1.04–2.79, P = 0.033). Subgroup analysis specifically in individuals with severe stroke (defined as National Institutes of Health Stroke Scale [NIHSS] ≥ 15) showed that hyperglycemia was a risk factor for low functional independence. Conclusion Increased post-procedural glucose is associated with poor functional outcome after endovascular treatment and an increased risk of symptomatic intracranial hemorrhage after endovascular treatment, especially for those with more severe strokes.
- Open Access
- 29 May 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1579659
Quantitative contrast enhancement volume on immediate post-thrombectomy CT predicts symptomatic intracranial hemorrhage and functional outcomes in acute large vessel occlusion stroke
Objectives: Symptomatic intracranial hemorrhage (sICH) following endovascular thrombectomy (EVT) for acute ischemic stroke due to anterior circulation large vessel occlusion (AIS-LVO) significantly impacts clinical outcomes. Contrast enhancement (CE) on immediate post-EVT non-contrast CT (NCCT) may reflect blood–brain barrier disruption, but its volumetric correlation with sICH and functional independence remains underexplored.Methods: We performed a retrospective screening on consecutive AIS-LVO patients who had CE on NCCT immediately within 2 h after EVT. The quantitative volume of CE was calculated by using 3D Slicer software. Multivariable logistic regression was performed to achieve the risk factors of sICH and functional independence. The discrimination and calibration of the multivariable models were assessed using the area under the receiver operator characteristic curve, fivefold cross-validation, calibration curve, and decision curve analysis.Results: In this study, 111 patients were enrolled in the final analysis. According to the restricted cubic spline, 10.6 mL was the optimal threshold of CE volume dichotomization for patients with AIS-LVO. In multivariate regression analysis, the CE+ group (CE volume beyond 10.6 mL) was significantly associated with sICH (aOR: 5.24, 95% CI: 1.45–18.99, p = 0.012) and functional independence (10.9% vs. 51.8%; aOR 0.05, 95% CI: 0.01–0.28, p < 0.001). The multivariable models demonstrated good discrimination and calibration in this cohort, as well as the fivefold cross-validation.Conclusion: Volumetric quantification of CE on immediate post-EVT NCCT serves as a novel biomarker for early sICH risk stratification and functional prognosis in AIS-LVO. Incorporating CE volume into predictive models enhances clinical utility, enabling timely diagnosis and intervention.
- 29 May 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1579659
Open AccessQuantitative contrast enhancement volume on immediate post-thrombectomy CT predicts symptomatic intracranial hemorrhage and functional outcomes in acute large vessel occlusion stroke
Objectives: Symptomatic intracranial hemorrhage (sICH) following endovascular thrombectomy (EVT) for acute ischemic stroke due to anterior circulation large vessel occlusion (AIS-LVO) significantly impacts clinical outcomes. Contrast enhancement (CE) on immediate post-EVT non-contrast CT (NCCT) may reflect blood–brain barrier disruption, but its volumetric correlation with sICH and functional independence remains underexplored.Methods: We performed a retrospective screening on consecutive AIS-LVO patients who had CE on NCCT immediately within 2 h after EVT. The quantitative volume of CE was calculated by using 3D Slicer software. Multivariable logistic regression was performed to achieve the risk factors of sICH and functional independence. The discrimination and calibration of the multivariable models were assessed using the area under the receiver operator characteristic curve, fivefold cross-validation, calibration curve, and decision curve analysis.Results: In this study, 111 patients were enrolled in the final analysis. According to the restricted cubic spline, 10.6 mL was the optimal threshold of CE volume dichotomization for patients with AIS-LVO. In multivariate regression analysis, the CE+ group (CE volume beyond 10.6 mL) was significantly associated with sICH (aOR: 5.24, 95% CI: 1.45–18.99, p = 0.012) and functional independence (10.9% vs. 51.8%; aOR 0.05, 95% CI: 0.01–0.28, p < 0.001). The multivariable models demonstrated good discrimination and calibration in this cohort, as well as the fivefold cross-validation.Conclusion: Volumetric quantification of CE on immediate post-EVT NCCT serves as a novel biomarker for early sICH risk stratification and functional prognosis in AIS-LVO. Incorporating CE volume into predictive models enhances clinical utility, enabling timely diagnosis and intervention.
- 14 May 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 474, 123538
The effect of cerebral collateral recycle on outcomes for patients with large ischemic infarct undergoing endovascular treatment
- 14 May 2025
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 474, 123538
The effect of cerebral collateral recycle on outcomes for patients with large ischemic infarct undergoing endovascular treatment
- 15 March 2025
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (7) , 3329-3331
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease presenting with meningoencephalitis: a case report
- 15 March 2025
- Published by Springer Nature in Neurological Sciences
- Vol. 46 (7) , 3329-3331
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease presenting with meningoencephalitis: a case report
- 9 December 2024
- Published by Elsevier in Academic Radiology
- Vol. 32 (5) , 2876-2885
Predicting Futile Recanalization by Cerebral Collateral Recycle Status in Patients with Endovascular Stroke Treatment: The CHANOA Score
- 9 December 2024
- Published by Elsevier in Academic Radiology
- Vol. 32 (5) , 2876-2885
Predicting Futile Recanalization by Cerebral Collateral Recycle Status in Patients with Endovascular Stroke Treatment: The CHANOA Score
- 5 December 2024
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 52 (1) , 101236
Impact of cerebral collateral recycle status on clinical outcomes in elderly patients with endovascular stroke treatment
- 5 December 2024
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 52 (1) , 101236
Impact of cerebral collateral recycle status on clinical outcomes in elderly patients with endovascular stroke treatment
- 23 July 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (9) , 967-973
The benefit of favorable venous outflow profiles is mediated through the reduced risk of intracranial hemorrhage in acute ischemic stroke patients undergoing endovascular treatment
Background Favorable venous outflow (VO) has been recognized as an independent predictor of excellent clinical outcomes in acute ischemic stroke caused by anterior circulation large vessel occlusion (AIS-LVO) patients who received endovascular treatment (EVT). However, the reasons why VO affects clinical outcomes have not been fully explained. In this study, we aimed to identify the potential mediators of VO affecting prognosis. Methods We conducted a multicenter retrospective cohort study of consecutive patients with AIS-LVO who underwent EVT. Baseline computed tomographic angiography (CTA) was applied to assess VO by the Cortical Vein Opacification Score (COVES). The primary outcome was functional independence at 90 days (modified Rankin Scale (mRS) score of 0–2). Classifying subtypes of intracranial hemorrhage (ICH) to explore the relationship between ICH subtypes and VO. Multivariate logistic regression and causal mediation analyses were used to evaluate the relationship among VO, functional independence, and potential mediators. Results Among 860 AIS-LVO patients undergoing EVT, a total of 515 patients were included in the present study after strict screening. In multivariate logistic regression analysis, favorable VO profiles (defined as COVES 3–6) were significantly associated with a lower incidence of ICH (24.2% vs 46.9%, adjusted odds ratio (aOR) 0.48, 95% confidence interval (CI) 0.30 to 0.77, P=0.002) and a higher proportion of functional independence (58.9% vs 15.0%, aOR 4.07, 95% CI 2.41 to 6.88, PConclusion This study demonstrated the potential mediating effects of severe ICH for the beneficial effect of favorable VO on clinical prognosis among patients with AIS-LVO who underwent EVT.
- 23 July 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 17 (9) , 967-973
The benefit of favorable venous outflow profiles is mediated through the reduced risk of intracranial hemorrhage in acute ischemic stroke patients undergoing endovascular treatment
Background Favorable venous outflow (VO) has been recognized as an independent predictor of excellent clinical outcomes in acute ischemic stroke caused by anterior circulation large vessel occlusion (AIS-LVO) patients who received endovascular treatment (EVT). However, the reasons why VO affects clinical outcomes have not been fully explained. In this study, we aimed to identify the potential mediators of VO affecting prognosis. Methods We conducted a multicenter retrospective cohort study of consecutive patients with AIS-LVO who underwent EVT. Baseline computed tomographic angiography (CTA) was applied to assess VO by the Cortical Vein Opacification Score (COVES). The primary outcome was functional independence at 90 days (modified Rankin Scale (mRS) score of 0–2). Classifying subtypes of intracranial hemorrhage (ICH) to explore the relationship between ICH subtypes and VO. Multivariate logistic regression and causal mediation analyses were used to evaluate the relationship among VO, functional independence, and potential mediators. Results Among 860 AIS-LVO patients undergoing EVT, a total of 515 patients were included in the present study after strict screening. In multivariate logistic regression analysis, favorable VO profiles (defined as COVES 3–6) were significantly associated with a lower incidence of ICH (24.2% vs 46.9%, adjusted odds ratio (aOR) 0.48, 95% confidence interval (CI) 0.30 to 0.77, P=0.002) and a higher proportion of functional independence (58.9% vs 15.0%, aOR 4.07, 95% CI 2.41 to 6.88, PConclusion This study demonstrated the potential mediating effects of severe ICH for the beneficial effect of favorable VO on clinical prognosis among patients with AIS-LVO who underwent EVT.
- 29 March 2024
- Published by Elsevier in Neurochemistry International
- Vol. 176, 105727
Sorbs2 regulates seizure activity by influencing AMPAR-mediated excitatory synaptic transmission in temporal lobe epilepsy
- 29 March 2024
- Published by Elsevier in Neurochemistry International
- Vol. 176, 105727
Sorbs2 regulates seizure activity by influencing AMPAR-mediated excitatory synaptic transmission in temporal lobe epilepsy